Understanding Imidocarb (CAS 27885-92-3): A Veterinary API Essential for Parasite Control
The fight against parasitic infections in animals is a continuous challenge in veterinary medicine. Among the critical pharmaceutical ingredients used for this purpose, Imidocarb (CAS 27885-92-3) plays a pivotal role as a potent antiprotozoal agent. Its efficacy in combating diseases like babesiosis and pyrozoonosis makes it an indispensable Active Pharmaceutical Ingredient (API) for manufacturers of veterinary drugs. Understanding the fundamentals of Imidocarb is key for anyone involved in the animal health sector, from researchers to procurement specialists.
Imidocarb, identified by its CAS number 27885-92-3, is a diamidine compound renowned for its effectiveness against a range of protozoan parasites that afflict livestock and companion animals. Its mechanism of action typically involves interfering with DNA synthesis and other vital metabolic processes within the parasite, leading to their demise. This makes it a highly effective treatment, particularly for infections that can be life-threatening if left untreated. The ability to buy Imidocarb means having access to a powerful tool for animal disease management.
The primary applications of Imidocarb are in the treatment of tick-borne protozoal diseases. In cattle and sheep, it is used to manage babesiosis and anaplasmosis, conditions that can severely impact herd health and productivity. For dogs, Imidocarb is also a crucial treatment for babesiosis, a serious condition often transmitted through tick bites. Its broad-spectrum activity against different species of Babesia makes it a versatile and essential medication. The demand for high-purity Imidocarb ensures that veterinary pharmaceuticals deliver optimal therapeutic outcomes.
For manufacturers and formulators, the sourcing of Imidocarb hinges on purity and consistency. A typical specification for this API is a purity of 99% or higher, ensuring that the final product is both safe and effective. Reputable manufacturers, such as those we partner with, ensure that their Imidocarb meets stringent quality standards, often complying with USP, BP, and EP pharmacopeias. This commitment to quality guarantees that when you purchase Imidocarb, you are receiving a product suitable for pharmaceutical use. We pride ourselves on being a leading Imidocarb manufacturer and supplier, offering this critical API with guaranteed high purity.
When considering the procurement of Imidocarb, buyers often look for a balance of quality and price. The competitive landscape, particularly with manufacturers in regions like China, offers opportunities to secure this vital API at favorable terms. Understanding the market price for Imidocarb and working with suppliers who offer bulk purchase options can significantly benefit your manufacturing operations. We are dedicated to providing our clients with competitive pricing and reliable supply, making us a preferred Imidocarb supplier for the global animal health industry.
In essence, Imidocarb (CAS 27885-92-3) is an indispensable veterinary API that plays a crucial role in controlling devastating parasitic diseases in animals. Its unique properties and broad application make it a staple in veterinary therapeutics. As a reliable manufacturer and supplier, we are committed to providing the highest quality Imidocarb to support the advancement of animal health worldwide. Contact us to discuss your needs for this essential pharmaceutical intermediate.
Perspectives & Insights
Alpha Spark Labs
“In cattle and sheep, it is used to manage babesiosis and anaplasmosis, conditions that can severely impact herd health and productivity.”
Future Pioneer 88
“For dogs, Imidocarb is also a crucial treatment for babesiosis, a serious condition often transmitted through tick bites.”
Core Explorer Pro
“Its broad-spectrum activity against different species of Babesia makes it a versatile and essential medication.”